Recombinant multi-species INCENP protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine INCENP protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
In mammalian cells, 2 broad groups of centromere-interacting proteins have been described: constitutively binding centromere proteins and 'passenger,' or transiently interacting, proteins (reviewed by Choo, 1997). The constitutive proteins include CENPA (centromere protein A; MIM 117139), CENPB (MIM 117140), CENPC1 (MIM 117141), and CENPD (MIM 117142). The term 'passenger proteins' encompasses a broad collection of proteins that localize to the centromere during specific stages of the cell cycle (Earnshaw and Mackay, 1994 [PubMed 8088460]). These include CENPE (MIM 117143); MCAK (MIM 604538); KID (MIM 603213); cytoplasmic dynein (e.g., MIM 600112); CliPs (e.g., MIM 179838); and CENPF/mitosin (MIM 600236). The inner centromere proteins (INCENPs) (Earnshaw and Cooke, 1991 [PubMed 1860899]), the initial members of the passenger protein group, display a broad localization along chromosomes in the early stages of mitosis but gradually become concentrated at centromeres as the cell cycle progresses into mid-metaphase. During telophase, the proteins are located within the midbody in the intercellular bridge, where they are discarded after cytokinesis (Cutts et al., 1999 [PubMed 10369859]).[supplied by OMIM, Mar 2008]
The Alternative Names of target: 2700067E22Rik,C130081E20,INCENP,Incenp,Inner centromere protein
Go
to INCENP products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP8305-Ag-1/ GM-Tg-hg-IP8305-Ag-2 | Human INCENP protein | Human |
| GM-Tg-rg-IP8305-Ag-1/ GM-Tg-rg-IP8305-Ag-2 | Rat INCENP protein | Rat |
| GM-Tg-mg-IP8305-Ag-1/ GM-Tg-mg-IP8305-Ag-2 | Mouse INCENP protein | Mouse |
| GM-Tg-cynog-IP8305-Ag-1/ GM-Tg-cynog-IP8305-Ag-2 | Cynomolgus/Rhesus macaque INCENP protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP8305-Ag-1/ GM-Tg-felg-IP8305-Ag-2 | Feline INCENP protein | Feline |
| GM-Tg-cang-IP8305-Ag-1/ GM-Tg-cang-IP8305-Ag-2 | Canine INCENP protein | Canine |
| GM-Tg-bovg-IP8305-Ag-1/ GM-Tg-bovg-IP8305-Ag-2 | Bovine INCENP protein | Bovine |
| GM-Tg-equg-IP8305-Ag-1/ GM-Tg-equg-IP8305-Ag-2 | Equine INCENP protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP8305-Ag-1/ GM-Tg-hg-IP8305-Ag-2;
GM-Tg-rg-IP8305-Ag-1/ GM-Tg-rg-IP8305-Ag-2;
GM-Tg-mg-IP8305-Ag-1/ GM-Tg-mg-IP8305-Ag-2; GM-Tg-cynog-IP8305-Ag-1/ GM-Tg-cynog-IP8305-Ag-2; GM-Tg-felg-IP8305-Ag-1/ GM-Tg-felg-IP8305-Ag-2; GM-Tg-cang-IP8305-Ag-1/ GM-Tg-cang-IP8305-Ag-2; GM-Tg-bovg-IP8305-Ag-1/ GM-Tg-bovg-IP8305-Ag-2; GM-Tg-equg-IP8305-Ag-1/ GM-Tg-equg-IP8305-Ag-2 |
| Products Name | INCENP protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | INCENP |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine INCENP protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.